Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.
2.

Choosing an atypical antipsychotic.

Sussman N.

Int Clin Psychopharmacol. 2002 Aug;17 Suppl 3:S29-33. Review.

PMID:
12570069
3.

Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.

Zhong KX, Sweitzer DE, Hamer RM, Lieberman JA.

J Clin Psychiatry. 2006 Jul;67(7):1093-103.

PMID:
16889453
4.

Use of antipsychotics in children and adolescents.

Findling RL, Steiner H, Weller EB.

J Clin Psychiatry. 2005;66 Suppl 7:29-40. Review.

5.

Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.

Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C.

J Clin Psychopharmacol. 2012 Jun;32(3):309-16. doi: 10.1097/JCP.0b013e3182549259. Review.

PMID:
22544019
6.

Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.

Aman MG, Gharabawi GM; Special Topic Advisory Panel on Transitioning to Risperidone Therapy in Patients With Mental Retardation and Developmental Disabilities.

J Clin Psychiatry. 2004 Sep;65(9):1197-210. Review.

PMID:
15367046
7.

The safety and tolerability of atypical antipsychotics in bipolar disorder.

Seemüller F, Forsthoff A, Dittmann S, Born C, Bernhard B, Severus WE, Grunze H.

Expert Opin Drug Saf. 2005 Sep;4(5):849-68. Review.

PMID:
16111448
8.

Implications of the CATIE trial on treatment: extrapyramidal symptoms.

Casey DE.

CNS Spectr. 2006 Jul;11(7 Suppl 7):25-31.

PMID:
16816797
9.
10.

Movement disorders associated with neuroleptic treatment.

Wirshing WC.

J Clin Psychiatry. 2001;62 Suppl 21:15-8. Review.

11.

A review of the effect of atypical antipsychotics on weight.

Nasrallah H.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:83-96. Review.

PMID:
12504074
12.

A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.

Luft B, Taylor D.

Expert Opin Pharmacother. 2006 Sep;7(13):1739-48. Review.

PMID:
16925501
13.

Safety and tolerability of antipsychotic treatment in young patients with schizophrenia.

Correll CU.

J Clin Psychiatry. 2011 Aug;72(8):e26. doi: 10.4088/JCP.9101tx5c.

15.

Pathophysiology of antipsychotic drug-induced movement disorders.

Casey DE.

J Clin Psychiatry. 2004;65 Suppl 9:25-8. Review.

16.

Adverse events in children and adolescents treated with antipsychotic medications.

Jerrell JM, McIntyre RS.

Hum Psychopharmacol. 2008 Jun;23(4):283-90. doi: 10.1002/hup.932.

PMID:
18302312
17.

Antipsychotics in pediatric and adolescent patients: a review of comparative safety data.

Ben Amor L.

J Affect Disord. 2012;138 Suppl:S22-30. doi: 10.1016/j.jad.2012.02.030. Epub 2012 Mar 8. Review.

PMID:
22405602
18.

The efficacy, safety, and tolerability of antipsychotics in the elderly.

Maixner SM, Mellow AM, Tandon R.

J Clin Psychiatry. 1999;60 Suppl 8:29-41. Review.

19.

Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care.

Nasrallah HA, Newcomer JW.

J Clin Psychopharmacol. 2004 Oct;24(5 Suppl 1):S7-14.

PMID:
15356415
20.

Supplemental Content

Support Center